🔗 Share this article

This year's Nobel Prize in medical science has been awarded for transformative findings that illuminate how the body's defense network targets harmful pathogens while protecting the body's own cells.

Three esteemed scientists—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

Their work identified unique "sentinels" within the defense system that remove malfunctioning defense cells that could attacking the body.

These findings are now paving the way for innovative therapies for autoimmune diseases and malignancies.

These laureates will divide a monetary award valued at 11m SEK.

Crucial Discoveries

"Their work has been decisive for understanding how the immune system operates and the reason we do not all develop severe self-attack conditions," stated the head of the Nobel Committee.

The team's studies address a fundamental question: How does the defense system protect us from numerous invaders while leaving our healthy cells unharmed?

Our immune system employs white blood cells that scan for signs of infection, even pathogens and bacteria it has never encountered.

These cells employ detectors—called recognition units—that are generated by chance in a vast number of combinations.

That provides the defense network the ability to fight a wide array of invaders, but the randomness of the process unavoidably produces white blood cells that may target the host.

Security Guards of the Immune System

Scientists earlier understood that a portion of these harmful white blood cells were destroyed in the thymus—where white blood cells develop.

The latest award recognizes the discovery of T-reg cells—described as the body's "peacekeepers"—which travel through the system to neutralize other immune cells that attack the body's own tissues.

We know that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

The prize committee added, "The discoveries have laid the foundation for a new field of investigation and accelerated the development of innovative treatments, for instance for cancer and autoimmune diseases."

Regarding malignancies, regulatory T-cells block the body from fighting the growth, so studies are focused on lowering their quantity.

In autoimmune diseases, experiments are testing boosting regulatory T-cells so the body is no longer under attack. A comparable method could also be effective in reducing the risks of organ transplant failure.

Pioneering Studies

Professor Sakaguchi, from Osaka University, performed tests on mice that had their immune gland extracted, causing autoimmune disease.

The researcher demonstrated that introducing defense cells from other animals could prevent the disease—implying there was a mechanism for preventing immune cells from attacking the host.

Dr. Brunkow, from the a research center in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an inherited autoimmune disease in mice and humans that resulted in the identification of a genetic factor vital for how regulatory T-cells operate.

"Their groundbreaking work has revealed how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly attacking the healthy cells," said a prominent biological science expert.

"This research is a remarkable example of how basic physiological research can have broad implications for public health."